Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial

  • Kristian Reich
  • , Jacob P. Thyssen
  • , Andrew Blauvelt
  • , Kilian Eyerich
  • , Weily Soong
  • , Zakiya P. Rice
  • , H. Chih ho Hong
  • , Norito Katoh
  • , Fernando Valenzuela
  • , Marco DiBonaventura
  • , Tamara A. Bratt
  • , Fan Zhang
  • , Claire Clibborn
  • , Ricardo Rojo
  • , Hernan Valdez
  • , Urs Kerkmann

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

188 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial“. Zusammen bilden sie einen einzigartigen Fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology